KCT0007695进行中（未招募）未知
A single-center, prospective, open-label, randomized, comparative, and placebocontrolled observation study for effect of using Mobile App-based Human Coaching Program on NAFLD
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 65(Year)（—）
- 性别
- All
入选标准
- •1. Male or female aged 19 years or older and under 65 years of age at the time of writing the written consent
- •2. Patients diagnosed with NAFLD (non-alcoholic fatty liver disease) as a result of ultrasound examination
- •3. Patients diagnosed with fatty liver (CAP value >238 dB/m) by transient elastography
- •4. Those who voluntarily consented in writing to the research
排除标准
- •1. Patients who meet the criteria for alcoholic fatty liver disease (in case of exceeding 210 g per week for men and 140 g per week for women for the past 2 years)
- •2. Patients with liver disease other than fatty liver
- •3. Cirrhosis patients with reduced liver function (CTP class B and C)
- •4. Those taking drugs that can cause fatty liver (thiazolidinedione, SGLT2i class, amiodarone, methotrexate, tamoxifen, valproate, corticosteroids, etc.)
- •5. Patients treated with oral or parenteral corticosteroids chronically (>14 consecutive days) within 8 weeks prior to screening
- •6. Patients with malnutrition, starvation, debilitating conditions (including patients with severe infections and severe trauma before and after surgery), pituitary insufficiency or adrenal insufficiency
- •7. Patients receiving or receiving radiation and chemotherapy for malignant tumors for less than 2 years
- •8. Patients undergoing gastrointestinal bypass
- •9. Heart failure (class III-IV in NYHA classification) or uncontrolled arrhythmias within 6 months
- •10. Those with acute cardiovascular disease within 12 weeks
- •(Patients with a history of unstable angina, myocardial infarction, transient ischemic attack, cerebrovascular disease, coronary artery bypass graft, or coronary intervention)
- •11. Patients with renal failure, chronic renal disease (estimated glomerular filtration rate <60 mL/min/1.73 m2) or patients on dialysis
- •12. Anemic patients with an Hb level of less than 10.5 g/dL
- •13. Others who are unable to participate in the research due to the judgment of the researcher
- •14. Persons unable to read consent forms (eg illiterate, foreigners, etc.)
研究者
相似试验
招募中
Unknown
A prospective, open-label, single-centre, randomized study to evaluate coronary microcirculation in de-novo lesions treated with drug-coated balloons or drug-eluting stentsCoronary artery diseaseJPRN-UMIN000052443Other50
尚未招募
Unknown
A single-center randomized, open-label, prospective study to evaluate efficacy and safety of DDK(Drug delivery kit, Welpass) for pain relief after gynecologic laparotomy surgeryKCT0008852Asan Medical Center110
尚未招募
4 期
Investigating the effect and safety of NEERI® Tablet and Syrup on kidney stonesCTRI/2023/07/054784Aimil Pharmaceuticals (India) Ltd.
招募中
3 期
ong term treatment study of 0.02% STN1013900 ophthalmic solution alone or in combination with either 0.005% Latanoprost ophthalmic solution, or 0.5%Timolol ophthalmic solution in subjects with open angle glaucoma or ocular hypertensioJPRN-jRCT2031210125Sakamoto Kayoko150
尚未招募
2 期
comparative clinical trial to evaluate safety and efficacy of test drug plus standard of care and standard of care alone in COVID 19 Acute Respiratory Distress Syndrome (ARDS) patients with non-invasive ventilation.CTRI/2021/12/038778Reliance Life Sciences Pvt Ltd